Anti-B7H4 monoclonal antibody-drug conjugate and methods of use

Details for Australian Patent Application No. 2008334063 (hide)

Owner Bristol-Myers Squibb Company

Inventors Chen, Bingliang; King, David J.; Terrett, Jonathan A.; Rao-Naik, Chetana; Cardarelli, Josephine M.

Agent Davies Collison Cave

Pub. Number AU-A-2008334063

PCT Pub. Number WO2009/073533

Priority 60/991,693 30.11.07 US

Filing date 26 November 2008

Wipo publication date 11 June 2009

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/073533 Priority application(s): WO2009/073533

20 January 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 and 19 Nov 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008334070-VEGF polymorphisms and antiangiogenesis therapy

2008334058-Compositions comprising vascular and myocyte progenitor cells and methods of their use